Toni M. Brand

2.1k citations

27 papers · 1.5k indexed · h-index 19

Oncology top 5%
- HER2/EGFR in Cancer Research 15
- Colorectal Cancer Treatments and Studies 3
- Lung Cancer Research Studies 3
- Pancreatic and Hepatic Oncology Research 3
Immunology top 10%
- Phagocytosis and Immune Regulation 3
Otorhinolaryngology top 5%
Cancer Research top 10%
Pulmonary and Respiratory Medicine top 10%
- Lung Cancer Treatments and Mutations 13
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 5
- Radiopharmaceutical Chemistry and Applications 3

Co-authors: Deric L. Wheeler Mari Iida Neha Luthar Chunrong Li Megan M. Starr Ravi Salgia Kelsey L. Corrigan Jennifer R. Grandis
Cited by: Oncology Immunology Otorhinolaryngology
Journals: Cancer Research (5 papers)Oncogene (2 papers)Clinical Cancer Research (2 papers)
Partner nations: United States Netherlands Canada

In The Last Decade

Toni M. Brand

26 papers receiving 1.5k citations

Peers

Countries citing papers authored by Toni M. Brand

Since Specialization

Citations

This map shows the geographic impact of Toni M. Brand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toni M. Brand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toni M. Brand more than expected).

Fields of papers citing papers by Toni M. Brand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toni M. Brand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toni M. Brand. The network helps show where Toni M. Brand may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Toni M. Brand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Toni M. Brand Line = papers co-authored together Toni M. Brand links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer Cancer Research ·Toni M. Brand,Stefan Hartmann,Neil E. Bhola,Hua Li,Yan Zeng,Rachel A. O’Keefe,Max V. Ranall,Sourav Bandyopadhyay,Margaret Soucheray,Nevan J. Krogan,Carolyn Kemp,Umamaheswar Duvvuri,Theresa LaVallee,Daniel E. Johnson,Michelle A. Ozbun,Julie E. Bauman,Jennifer R. Grandis	2018	31
2	Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus–Host Protein Network Cancer Discovery ·Manon Eckhardt,Wei Zhang,Andrew M. Gross,John Von Dollen,Jeffrey R. Johnson,Kathleen E. Franks-Skiba,Danielle L. Swaney,Tasha L. Johnson,Gwendolyn Μ. Jang,Priya S. Shah,Toni M. Brand,Jacques Archambault,Jason F. Kreisberg,Jennifer R. Grandis,Trey Ideker,Nevan J. Krogan	2018	63
3	Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation Oncogene ·Nicole Michael Frazier,Toni M. Brand,John D. Gordan,Jennifer R. Grandis,Natalia Jura	2018	25
4	BET Inhibition Overcomes Receptor Tyrosine Kinase–Mediated Cetuximab Resistance in HNSCC Cancer Research ·Brandon Leonard,Toni M. Brand,Rachel A. O’Keefe,Eliot D. Lee,Yan Zeng,Jacquelyn D. Kemmer,Hua Li,Jennifer R. Grandis,Neil E. Bhola	2018	70
5	Multidimensionality of Socioeconomic Status and its Effect on Health Outcomes in Contemporary Estonia Lund University Publications Student Papers (Lund University) ·Toni M. Brand	2018	0
6	Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients Clinical Cancer Research ·Toni M. Brand,Stefan Hartmann,Neil E. Bhola,Noah D. Peyser,Hua Li,Yan Zeng,Erin Isaacson Wechsler,Max V. Ranall,Sourav Bandyopadhyay,Umamaheswar Duvvuri,Theresa LaVallee,Richard C. Jordan,Daniel E. Johnson,Jennifer R. Grandis	2016	44
7	Adaptive responses to antibody based therapy Seminars in Cell and Developmental Biology ·Tamara S. Rodems,Mari Iida,Toni M. Brand,Hannah E. Pearson,Rachel A. Orbuch,Bailey G. Flanigan,Deric L. Wheeler	2016	5
8	Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab Molecular Cancer Therapeutics ·Mari Iida,Harsh Bahrar,Toni M. Brand,Hannah E. Pearson,John P. Coan,Rachel A. Orbuch,Bailey G. Flanigan,Adam D. Swick,Prashanth J. Prabakaran,Johan Lantto,Ivan D. Horak,Michael Kragh,Ravi Salgia,Randall J. Kimple,Deric L. Wheeler	2016	33
9	AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma Clinical Cancer Research ·Toni M. Brand,Mari Iida,Andrew P. Stein,Kelsey L. Corrigan,Cara M. Braverman,John P. Coan,Hannah E. Pearson,Harsh Bahrar,Tyler L. Fowler,Bryan P. Bednarz,Sandeep Saha,David T. Yang,Parkash S. Gill,Mark W. Lingen,Vassiliki Saloura,Victoria Villaflor,Ravi Salgia,Randall J. Kimple,Deric L. Wheeler	2015	89
10	Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer Molecular Cancer Therapeutics ·Toni M. Brand,Mari Iida,Emily Dunn,Neha Luthar,Kellie T. Kostopoulos,Kelsey L. Corrigan,Matthew J. Wleklinski,David T. Yang,Kari B. Wisinski,Ravi Salgia,Deric L. Wheeler	2014	40
11	AXL Mediates Resistance to Cetuximab Therapy Cancer Research ·Toni M. Brand,Mari Iida,Andrew P. Stein,Kelsey L. Corrigan,Cara M. Braverman,Neha Luthar,Mahmoud Toulany,Parkash S. Gill,Ravi Salgia,Randall J. Kimple,Deric L. Wheeler	2014	150
12	Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy Molecular Cancer ·Mari Iida,Toni M. Brand,Megan M. Starr,Evan J Huppert,Neha Luthar,Harsh Bahrar,John P. Coan,Hannah E. Pearson,Ravi Salgia,Deric L. Wheeler	2014	49
13	Nuclear EGFR as a molecular target in cancer Radiotherapy and Oncology ·Toni M. Brand,Mari Iida,Neha Luthar,Megan M. Starr,Evan J Huppert,Deric L. Wheeler	2013	188
14	Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer Lung Cancer ·Anne M. Traynor,Tracey L. Weigel,Kurt R. Oettel,David T. Yang,Chong Zhang,KyungMann Kim,Ravi Salgia,Mari Iida,Toni M. Brand,Tien Hoang,Toby C. Campbell,Hilary R. Hernan,Deric L. Wheeler	2013	57
15	Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximab Cancer Biology & Therapy ·Mari Iida,Toni M. Brand,David A. Campbell,Megan M. Starr,Neha Luthar,Anne M. Traynor,Deric L. Wheeler	2013	40
16	Sym004, a Novel EGFR Antibody Mixture, Can Overcome Acquired Resistance to Cetuximab Neoplasia ·Mari Iida,Toni M. Brand,Megan M. Starr,Chunrong Li,Evan J Huppert,Neha Luthar,Mikkel W. Pedersen,Ivan D. Horak,Michael Kragh,Deric L. Wheeler	2013	58
17	Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor Oncogene ·Mari Iida,Toni M. Brand,David A. Campbell,C Li,Deric L. Wheeler	2012	66
18	Erlotinib is a viable treatment for tumors with acquired resistance to cetuximab Cancer Biology & Therapy ·Toni M. Brand,Emily Dunn,Mari Iida,Rebecca A. Myers,Kellie T. Kostopoulos,Chunrong Li,Chimera R. Peet,Deric L. Wheeler	2011	12
19	Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab Cancer Biology & Therapy ·Toni M. Brand,Mari Iida,Deric L. Wheeler	2011	206
20	The nuclear epidermal growth factor receptor signaling network and its role in cancer. PubMed ·Toni M. Brand,Mari Iida,Chunrong Li,Deric L. Wheeler	2011	174

About Toni M. Brand

Toni M. Brand is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 1.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (15 papers), Lung Cancer Treatments and Mutations (13 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Research Studies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Phagocytosis and Immune Regulation (3 papers). The work is most often cited by research in Oncology (807 citations), Immunology (276 citations) and Otorhinolaryngology (57 citations). Toni M. Brand has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Deric L. Wheeler, Mari Iida, Neha Luthar, Chunrong Li, Megan M. Starr, Ravi Salgia, Kelsey L. Corrigan, Jennifer R. Grandis, Randall J. Kimple and David A. Campbell. Their work appears in journals such as Cancer Research, Oncogene and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact